Epidemiological observations suggest that the incidence of Alzheimer’s disease is unusually low in certain regions of India, with estimates indicating that roughly 1% of individuals over the age of 65 are affected in some rural villages. While many factors may contribute to this difference—including genetics, lifestyle, diet, and diagnostic practices—dietary patterns have received particular attention.
Curcumin is a naturally occurring antioxidant found in turmeric, a perennial plant botanically related to ginger and native to India, China, and Indonesia. Turmeric is a major component of curry powder and prepared mustard, and it has a long history of use in both traditional Chinese medicine and Indian Ayurvedic medicine, primarily for its anti-inflammatory properties.
Researchers have proposed that regular dietary exposure to curcumin may influence mechanisms involved in Alzheimer’s disease. Curcumin has been shown in experimental models to reduce oxidative stress and interfere with the accumulation of amyloid plaques—protein deposits that are a hallmark of Alzheimer’s pathology.
Dr. Sally Frautschy of University of California, Los Angeles presented research on this topic at the 2005 annual meeting of the Society for Neuroscience in San Diego, California. Her paper, Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse, reported that curcumin supplementation reduced amyloid plaque formation and markers of oxidative damage in a mouse model of Alzheimer’s disease.
While these findings do not prove that curry consumption prevents Alzheimer’s disease in humans, they suggest a plausible biological mechanism that may help explain observed population differences and justify further research.
